Cannabinoids and Vanilloids in Schizophrenia: Neurophysiological Evidence and Directions for Basic Research

Much of our knowledge of the endocannabinoid system in schizophrenia comes from behavioral measures in rodents, like prepulse inhibition of the acoustic startle and open-field locomotion, which are commonly used along with neurochemical approaches or drug challenge designs. Such methods continue to...

Descripción completa

Detalles Bibliográficos
Autores principales: Ruggiero, Rafael N., Rossignoli, Matheus T., De Ross, Jana B., Hallak, Jaime E. C., Leite, Joao P., Bueno-Junior, Lezio S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2017
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5478733/
https://www.ncbi.nlm.nih.gov/pubmed/28680405
http://dx.doi.org/10.3389/fphar.2017.00399

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5478733/
https://www.ncbi.nlm.nih.gov/pubmed/28680405
http://dx.doi.org/10.3389/fphar.2017.00399

Ejemplares similares